The University of Chicago Header Logo

Sonali Smith

InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Smith S. Too much and not enough: revisiting maintenance rituximab in indolent lymphomas. Haematologica. 2022 02 01; 107(2):353-354. PMID: 34134474; PMCID: PMC8804557.
      Citations:    Fields:    Translation:Humans
    2. Smith SM, Salles G. Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges. Haematologica. 2022 01 01; 107(1):4-6. PMID: 34985229; PMCID: PMC8719072.
      Citations:    Fields:    
    3. Smith SM, Pitcher BN, Jung SH, Bartlett NL, Wagner-Johnston N, Park SI, Richards KL, Cashen AF, Jaslowski A, Smith SE, Cheson BD, Hsi E, Leonard JP. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Lancet Haematol. 2017 Apr; 4(4):e176-e182. PMID: 28314699; PMCID: PMC5499150.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    4. Smith SM. New drugs for the treatment of non-Hodgkin lymphomas. Chin Clin Oncol. 2015 Mar; 4(1):14. PMID: 25841721.
      Citations: 2     Fields:    Translation:HumansCells
    5. Smith SM, Johnson JL, Jung SH, Bartlett NL, Cheson BD, Alliance for Clinical Trials in Oncology, Schöder H. The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul; 54(7):1405-10. PMID: 23194022; PMCID: PMC5499151.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    6. Smith SM. Maintenance rituximab revisited: is it worth the cost? Leuk Lymphoma. 2012 Dec; 53(12):2331-2. PMID: 22680766.
      Citations:    Fields:    Translation:Humans
    7. Smith SM. Targeting mTOR in mantle cell lymphoma: current and future directions. Best Pract Res Clin Haematol. 2012 Jun; 25(2):175-83. PMID: 22687453.
      Citations: 5     Fields:    Translation:HumansCells
    8. Smith SM, van Besien K, Karrison T, Dancey J, McLaughlin P, Younes A, Smith S, Stiff P, Lester E, Modi S, Doyle LA, Vokes EE, Pro B. Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. J Clin Oncol. 2010 Nov 01; 28(31):4740-6. PMID: 20837940; PMCID: PMC3020703.
      Citations: 77     Fields:    Translation:HumansCTClinical Trials
    9. Smith SM, Johnson J, Cheson BD, Canellos G, Petroni G, Oken M, Duggan D, Hurd D, Gockerman JP, Parker B, Prchal J, Peterson BA, Cancer and Leukemia Group B, Eastern Cooperative Oncology Group. Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma. 2009 Oct; 50(10):1606-17. PMID: 19626540; PMCID: PMC5765852.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    10. Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PL, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Hari P. Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biol Blood Marrow Transplant. 2008 Aug; 14(8):904-12. PMID: 18640574; PMCID: PMC3353768.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    11. Smith SM, Grinblatt D, Johnson JL, Niedzwiecki D, Rizzieri D, Bartlett NL, Cheson BD, Cancer and Leukemia Group B. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol. 2008 Feb; 140(3):313-9. PMID: 18217897.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    12. Smith SM, Johnson JL, Niedzwiecki D, Eder JP, Canellos G, Cheson BD, Bartlett NL, Cancer and Leukemia Group B. Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leuk Lymphoma. 2006 Aug; 47(8):1511-7. PMID: 16966261.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    13. Smith SM. Reduced-intensity transplantation for lymphoma. Curr Treat Options Oncol. 2006 Jul; 7(4):295-305. PMID: 16916490.
      Citations: 2     Fields:    Translation:Humans
    14. Smith S. Something old, something new.... Leuk Lymphoma. 2006 Apr; 47(4):576-7. PMID: 16886269.
      Citations:    Fields:    Translation:Humans
    15. Smith SM. Nonmyeloablative transplantation for lymphoma. Curr Treat Options Oncol. 2003 Aug; 4(4):261-8. PMID: 12943606.
      Citations:    Fields:    Translation:Humans
    Smith's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (86)
    Co-Authors (4)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors